FR2445719A1 - Renal calculus treatment with sequestrant - comprising (co)polymer of unsatd. carboxylic acid - Google Patents
Renal calculus treatment with sequestrant - comprising (co)polymer of unsatd. carboxylic acidInfo
- Publication number
- FR2445719A1 FR2445719A1 FR7900253A FR7900253A FR2445719A1 FR 2445719 A1 FR2445719 A1 FR 2445719A1 FR 7900253 A FR7900253 A FR 7900253A FR 7900253 A FR7900253 A FR 7900253A FR 2445719 A1 FR2445719 A1 FR 2445719A1
- Authority
- FR
- France
- Prior art keywords
- pref
- polymer
- treatment
- unsatd
- renal calculus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
Abstract
Treatment of renal calculus comprises administering a (co)polymer (I) derived from an olefinically unsatd. mono- or polycarboxylic acid (II). If (I) is water-soluble, it has mol. wt. >10000, and if it forms colloidal aq. solns. it has swelling index >=10 (pref. 10-500). Unit dose compsns. contain 0.1-20 g of (I), opt. in slat form. Pref. (II) include acrylic, (m)ethacrylic, alpha-chloroacrylic, +-cyanoacrylic, crotonic, beta-acryloxypropionic, hydrosorbic, sorbic, alpha-chlorosorbic, cinnamic, beta-styrylacrylic, hydromuconic, itaconic, citraconic, mesaconic, muconic, glutaconic and aconitic acids. (I) dissolve calculi and bond calcium so that it is excreted in faeces rather than urine. They are effective in treatment of urolithiasis in lower doses than phosphates, and are easily dosed since they can be administered in liquid form. Daily dose is pref. 10-400 mg/kg p.o.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7900253A FR2445719A1 (en) | 1979-01-05 | 1979-01-05 | Renal calculus treatment with sequestrant - comprising (co)polymer of unsatd. carboxylic acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7900253A FR2445719A1 (en) | 1979-01-05 | 1979-01-05 | Renal calculus treatment with sequestrant - comprising (co)polymer of unsatd. carboxylic acid |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2445719A1 true FR2445719A1 (en) | 1980-08-01 |
FR2445719B1 FR2445719B1 (en) | 1985-04-12 |
Family
ID=9220496
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7900253A Granted FR2445719A1 (en) | 1979-01-05 | 1979-01-05 | Renal calculus treatment with sequestrant - comprising (co)polymer of unsatd. carboxylic acid |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2445719A1 (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3962420A (en) * | 1974-07-03 | 1976-06-08 | Rohm And Haas Company | Dissolution of gallstones |
-
1979
- 1979-01-05 FR FR7900253A patent/FR2445719A1/en active Granted
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3962420A (en) * | 1974-07-03 | 1976-06-08 | Rohm And Haas Company | Dissolution of gallstones |
Also Published As
Publication number | Publication date |
---|---|
FR2445719B1 (en) | 1985-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4885281A (en) | Sucralfate suspension | |
US4842847A (en) | Dental calculus inhibiting compositions | |
Zinberg et al. | Reversible symptomatic biliary obstruction associated with ceftriaxone pseudolithiasis. | |
EP0341660A2 (en) | Tartar inhibition on teeth | |
CH642535A5 (en) | PERMANENT AQUEOUS COMPOSITION FOR REMINERALIZING ENAMEL. | |
JPH02117612A (en) | Antihydrolytic agent for odontology | |
Wall et al. | Long-term acidification of urine in patients treated for infected renal stones | |
BG106763A (en) | Paediatric phamaceutical composition | |
US4387093A (en) | Arthritis treatment | |
EP0083032A3 (en) | Adjuvants for rectal delivery of drug substances | |
FR2445719A1 (en) | Renal calculus treatment with sequestrant - comprising (co)polymer of unsatd. carboxylic acid | |
WO1995004528A3 (en) | PHARMACEUTICAL COMPOSITION CONTAINING A DRUG/β-CYCLODEXTRIN COMPLEX IN COMBINATION WITH AN ACID-BASE COUPLE | |
US3621094A (en) | Concentrated aqueous liquid antacid compositions containing certain phosphate and gluconate salts | |
Foulkes et al. | A comparative evaluation of cimetidine and sodium citrate to decrease gastric acidity: effectiveness at the time of induction of anaesthesia | |
GR3023074T3 (en) | Novel pharmaceutical composition for the preparation of a stable powder containing an active principle comprising an association of acetylsalicylic acid and metoclopramide | |
HK1016408A1 (en) | Use of a combination of antineoplastons for the manufacture of a medicament for the treatment of neurofibromatosis | |
US2967131A (en) | Therapeutic composition | |
Alexander et al. | Treatment of uric acid urolithiasis with allopurinol: a xanthine oxidase inhibitor | |
Simonian et al. | Nonsurgical control of massive acute gastric mucosal hemorrhage with antacid neutralization of gastric content | |
ATE32980T1 (en) | PH INDEPENDENT CONTROLLED RELEASE TABLETS. | |
Ranløv et al. | Faecal blood loss during administration of acetylsalicylic acid, ketoprofen and two new ketoprofen sustained-release compounds | |
PT81309B (en) | METHOD FOR THE PREPARATION OF FLUIDIFIED AND REHATRATABLE MAGALDRATE COMPOSITIONS | |
Green Jr et al. | Pharmacology and clinical use of antacids | |
Thomas et al. | Toxic shock syndrome: A review of the literature | |
Weismann et al. | Effects of tetracycline on the absorption of 65 Zinc in rats |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |